Last 12 months
Inside the activity.
0 purchase rows · 2 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 2 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| April 19, 2024 Filed Apr 23, 2024 19:22 UTC |
Marsh Martha H.Director
|
Exercise / conversionRestricted Stock Units · Derivative | 1,681 | $0.00 | $0.00 |
DisclosureSEC source: 0001142750-24-000030 · wk-form4_1713900120.xml · derivative · entry 4 Marsh Martha H. · CIK 0001500281 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,681 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_price: The RSUs were granted pursuant to the AMN Healthcare 2017 Equity Plan. Each RSU represents a contingent right to receive one share of AMN Common Stock. F5 · derivative.exercise_date: The RSUs identified in this row were granted on May 17, 2023 and vest on the earlier of (i) the one year anniversary of the grant date, or (ii) the date of the Company's Annual Meeting of Shareholders in 2024. Accordingly, the number of RSUs identified in this row vested on April 19, 2024. F6 · derivative.expiration_date: RSUs do not have an expiration date. Read SEC document |
| April 19, 2024 Filed Apr 23, 2024 19:22 UTC |
Marsh Martha H.Director
|
Exercise / conversionCommon Stock | 22,575 | $0.00 | $0.00 |
DisclosureSEC source: 0001142750-24-000030 · wk-form4_1713900120.xml · nonDerivative · entry 3 Marsh Martha H. · CIK 0001500281 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 56,029 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · kind: The acquisition of Common Stock set forth in this row resulted from the deferred release of a RSU award granted on April 18, 2012. The reporting person elected to defer receipt of these RSUs until her retirement from the Company's Board of Directors. Read SEC document |
| April 19, 2024 Filed Apr 23, 2024 19:22 UTC |
Marsh Martha H.Director
|
Exercise / conversionCommon Stock | 6,275 | $0.00 | $0.00 |
DisclosureSEC source: 0001142750-24-000030 · wk-form4_1713900120.xml · nonDerivative · entry 2 Marsh Martha H. · CIK 0001500281 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 33,454 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · kind: The acquisition of Common Stock set forth in this row resulted from the deferred release of a RSU award granted on September 21, 2010. The reporting person elected to defer receipt of these RSUs until her retirement from the Company's Board of Directors. Read SEC document |
| April 19, 2024 Filed Apr 23, 2024 19:22 UTC |
Marsh Martha H.Director
|
Exercise / conversionCommon Stock | 1,681 | $0.00 | $0.00 |
DisclosureSEC source: 0001142750-24-000030 · wk-form4_1713900120.xml · nonDerivative · entry 1 Marsh Martha H. · CIK 0001500281 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 27,179 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: AMN Common Stock acquired on the vesting of Restricted Stock Units ("RSUs"). Read SEC document |
| April 19, 2024 Filed Apr 23, 2024 19:18 UTC |
Caballero Jorge A.Director
|
Exercise / conversionRestricted Stock Units · Derivative | 1,681 | $0.00 | $0.00 |
DisclosureSEC source: 0001142750-24-000028 · wk-form4_1713899883.xml · derivative · entry 3 Caballero Jorge A. · CIK 0001899928 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,681 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: The RSUs were granted pursuant to the AMN Healthcare 2017 Equity Plan. Each RSU represents a contingent right to receive one share of AMN Common Stock. F5 · derivative.exercise_date: The RSUs identified in this row were granted on May 17, 2023 and vest on the earlier of (i) the one year anniversary of the grant date, or (ii) the date of the Company's Annual Meeting of Shareholders in 2024. Accordingly, the number of RSUs identified in this row vested on April 19, 2024. F4 · derivative.expiration_date: RSUs do not have an expiration date. Read SEC document |
| April 19, 2024 Filed Apr 23, 2024 19:18 UTC |
Caballero Jorge A.Director
|
GrantRestricted Stock Units · Derivative | 3,019 | $0.00 | $0.00 |
DisclosureSEC source: 0001142750-24-000028 · wk-form4_1713899883.xml · derivative · entry 2 Caballero Jorge A. · CIK 0001899928 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,019 Underlying: Common Stock · 3,019 shares Expires not disclosed F2 · derivative.exercise_price: The RSUs were granted pursuant to the AMN Healthcare 2017 Equity Plan. Each RSU represents a contingent right to receive one share of AMN Common Stock. F3 · derivative.exercise_date: The RSUs identified in this row were granted on April 19, 2024 and vest on the earlier of (i) the one year anniversary of the grant date, or (ii) the date of the Company's Annual Meeting of Shareholders in 2025. F4 · derivative.expiration_date: RSUs do not have an expiration date. Read SEC document |
| April 19, 2024 Filed Apr 23, 2024 19:18 UTC |
Caballero Jorge A.Director
|
Exercise / conversionCommon Stock | 1,681 | $0.00 | $0.00 |
DisclosureSEC source: 0001142750-24-000028 · wk-form4_1713899883.xml · nonDerivative · entry 1 Caballero Jorge A. · CIK 0001899928 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,118 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: AMN Common Stock acquired on the vesting of Restricted Stock Units ("RSUs"). Read SEC document |
| April 19, 2024 Filed Apr 23, 2024 19:19 UTC |
HARRIS R JEFFREYDirector
|
Exercise / conversionRestricted Stock Units · Derivative | 1,681 | $0.00 | $0.00 |
DisclosureSEC source: 0001142750-24-000029 · wk-form4_1713899944.xml · derivative · entry 3 HARRIS R JEFFREY · CIK 0001183645 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,681 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: The RSUs were granted pursuant to the AMN Healthcare 2017 Equity Plan. Each RSU represents a contingent right to receive one share of AMN Common Stock. F5 · derivative.exercise_date: The RSUs identified in this row were granted on May 17, 2023 and vest on the earlier of (i) the one year anniversary of the grant date, or (ii) the date of the Company's Annual Meeting of Shareholders in 2024. Accordingly, the number of RSUs identified in this row vested on April 19, 2024. F4 · derivative.expiration_date: RSUs do not have an expiration date. Read SEC document |
| April 19, 2024 Filed Apr 23, 2024 19:19 UTC |
HARRIS R JEFFREYDirector
|
GrantRestricted Stock Units · Derivative | 3,019 | $0.00 | $0.00 |
DisclosureSEC source: 0001142750-24-000029 · wk-form4_1713899944.xml · derivative · entry 2 HARRIS R JEFFREY · CIK 0001183645 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,019 Underlying: Common Stock · 3,019 shares Expires not disclosed F2 · derivative.exercise_price: The RSUs were granted pursuant to the AMN Healthcare 2017 Equity Plan. Each RSU represents a contingent right to receive one share of AMN Common Stock. F3 · derivative.exercise_date: The RSUs identified in this row were granted on April 19, 2024 and vest on the earlier of (i) the one year anniversary of the grant date, or (ii) the date of the Company's Annual Meeting of Shareholders in 2025. F4 · derivative.expiration_date: RSUs do not have an expiration date. Read SEC document |
| April 19, 2024 Filed Apr 23, 2024 19:19 UTC |
HARRIS R JEFFREYDirector
|
Exercise / conversionCommon Stock | 1,681 | $0.00 | $0.00 |
DisclosureSEC source: 0001142750-24-000029 · wk-form4_1713899944.xml · nonDerivative · entry 1 HARRIS R JEFFREY · CIK 0001183645 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 55,918 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: AMN Common Stock acquired on the vesting of Restricted Stock Units ("RSUs"). Read SEC document |
| April 19, 2024 Filed Apr 23, 2024 19:15 UTC |
WHEAT DOUGLAS DDirector
|
Exercise / conversionRestricted Stock Units · Derivative | 1,681 | $0.00 | $0.00 |
DisclosureSEC source: 0001142750-24-000027 · wk-form4_1713899739.xml · derivative · entry 3 WHEAT DOUGLAS D · CIK 0001158599 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,681 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_price: The RSUs were granted pursuant to the AMN Healthcare 2017 Equity Plan. Each RSU represents a contingent right to receive one share of AMN Common Stock F6 · derivative.exercise_date: The RSUs identified in this row were granted on May 17, 2023 and vest on the earlier of (i) the one year anniversary of the grant date, or (ii) the date of the Company's Annual Meeting of Shareholders in 2024. Accordingly, the number of RSUs identified in this row vested on April 19, 2024. F4 · derivative.expiration_date: RSUs do not have an expiration date. Read SEC document |
| April 19, 2024 Filed Apr 23, 2024 19:15 UTC |
WHEAT DOUGLAS DDirector
|
GrantRestricted Stock Units · Derivative | 3,019 | $0.00 | $0.00 |
DisclosureSEC source: 0001142750-24-000027 · wk-form4_1713899739.xml · derivative · entry 2 WHEAT DOUGLAS D · CIK 0001158599 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,019 Underlying: Common Stock · 3,019 shares Expires not disclosed F2 · derivative.exercise_price: The RSUs were granted pursuant to the AMN Healthcare 2017 Equity Plan. Each RSU represents a contingent right to receive one share of AMN Common Stock. F3 · derivative.exercise_date: The RSUs identified in this row were granted on April 19, 2024 and vest on the earlier of (i) the one year anniversary of the grant date, or (ii) the date of the Company's Annual Meeting of Shareholders in 2025. F4 · derivative.expiration_date: RSUs do not have an expiration date. Read SEC document |
| April 19, 2024 Filed Apr 23, 2024 19:15 UTC |
WHEAT DOUGLAS DDirector
|
Exercise / conversionCommon Stock | 1,681 | $0.00 | $0.00 |
DisclosureSEC source: 0001142750-24-000027 · wk-form4_1713899739.xml · nonDerivative · entry 1 WHEAT DOUGLAS D · CIK 0001158599 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,824 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: AMN Common Stock acquired on the vesting of Restricted Stock Units ("RSUs"). Read SEC document |
| April 19, 2024 Filed Oct 16, 2024 15:45 UTC Amendment |
Caballero Jorge A.Director
|
Exercise / conversionRestricted Stock Units · Derivative | 1,681 | $0.00 | $0.00 |
DisclosureSEC source: 0001142750-24-000053 · wk-form4a_1729093515.xml · derivative · entry 3 Caballero Jorge A. · CIK 0001899928 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,681 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: The RSUs were granted pursuant to the AMN Healthcare 2017 Equity Plan. Each RSU represents a contingent right to receive one share of AMN Common Stock. F6 · derivative.exercise_date: The RSUs identified in this row were granted on May 17, 2023 and vest on the earlier of (i) the one year anniversary of the grant date, or (ii) the date of the Company's Annual Meeting of Shareholders in 2024. Accordingly, the number of RSUs identified in this row vested on April 19, 2024. F5 · derivative.expiration_date: RSUs do not have an expiration date. Read SEC document |
| April 19, 2024 Filed Oct 16, 2024 15:45 UTC Amendment |
Caballero Jorge A.Director
|
GrantRestricted Stock Units · Derivative | 3,019 | $0.00 | $0.00 |
DisclosureSEC source: 0001142750-24-000053 · wk-form4a_1729093515.xml · derivative · entry 2 Caballero Jorge A. · CIK 0001899928 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,019 Underlying: Common Stock · 3,019 shares Expires not disclosed F3 · derivative.exercise_price: The RSUs were granted pursuant to the AMN Healthcare 2017 Equity Plan. Each RSU represents a contingent right to receive one share of AMN Common Stock. F4 · derivative.exercise_date: The RSUs identified in this row were granted on April 19, 2024 and vest on the earlier of (i) the one year anniversary of the grant date, or (ii) the date of the Company's Annual Meeting of Shareholders in 2025. F5 · derivative.expiration_date: RSUs do not have an expiration date. Read SEC document |
| April 19, 2024 Filed Oct 16, 2024 15:45 UTC Amendment |
Caballero Jorge A.Director
|
Exercise / conversionCommon Stock | 1,681 | $0.00 | $0.00 |
DisclosureSEC source: 0001142750-24-000053 · wk-form4a_1729093515.xml · nonDerivative · entry 1 Caballero Jorge A. · CIK 0001899928 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,118 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: AMN Common Stock acquired on the vesting of Restricted Stock Units ("RSUs"). F2 · balance_after: Due to an administrative error, the Form 4 filed by the reporting person on April 23, 2024 understated the amount of securities beneficially owned following the reported transaction by 2,000 shares. This Form 4 is being amended and restated to reflect that, following the reported transaction, 4,118 securities were beneficially owned by reporting person, not 2,118 as previously reported. Read SEC document |
| March 06, 2024 Filed Mar 7, 2024 18:45 UTC |
Caballero Jorge A.Director
|
PurchaseCommon Stock | 2,000 | $56.80 | $113,600.00 |
DisclosureSEC source: 0001209191-24-004616 · doc4.xml · nonDerivative · entry 1 Caballero Jorge A. · CIK 0001899928 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,437 Read SEC document |
| March 04, 2024 Filed Mar 4, 2024 23:16 UTC |
Fontenot Teri G.Director
|
PurchaseCommon Stock | 1,732 | $57.64 | $99,832.48 |
DisclosureSEC source: 0001142750-24-000026 · wk-form4_1709594172.xml · nonDerivative · entry 1 Fontenot Teri G. · CIK 0001661066 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,558 Read SEC document |
| February 29, 2024 Filed Mar 1, 2024 20:58 UTC |
HARRIS R JEFFREYDirector
|
PurchaseCommon Stock | 2,640 | $56.97 | $150,400.80 |
DisclosureSEC source: 0001142750-24-000025 · wk-form4_1709326720.xml · nonDerivative · entry 1 HARRIS R JEFFREY · CIK 0001183645 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 54,237 Read SEC document |
| February 29, 2024 Filed Mar 1, 2024 20:57 UTC |
FOLETTA MARK GDirector
|
PurchaseCommon Stock | 500 | $56.90 | $28,450.00 |
DisclosureSEC source: 0001142750-24-000024 · wk-form4_1709326663.xml · nonDerivative · entry 1 FOLETTA MARK G · CIK 0001236389 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,573 Read SEC document |
| February 28, 2024 Filed Feb 29, 2024 01:44 UTC | PurchaseCommon Stock | 6,951 | $57.75 | $401,420.25 |
DisclosureSEC source: 0001142750-24-000023 · wk-form4_1709171052.xml · nonDerivative · entry 1 Knudson Jeffrey R · CIK 0001752946 · CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 27,804 Read SEC document |
|
| February 28, 2024 Filed Feb 28, 2024 22:41 UTC |
Trent-Adams SylviaDirector
|
PurchaseCommon Stock | 175 | $57.02 | $9,978.50 |
DisclosureSEC source: 0001142750-24-000022 · wk-form4_1709160052.xml · nonDerivative · entry 1 Trent-Adams Sylvia · CIK 0001826381 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,772 Read SEC document |
| February 28, 2024 Filed Feb 28, 2024 22:39 UTC |
WHEAT DOUGLAS DDirector
|
PurchaseCommon Stock | 2,620 | $56.87 | $148,999.40 |
DisclosureSEC source: 0001142750-24-000021 · wk-form4_1709159965.xml · nonDerivative · entry 1 WHEAT DOUGLAS D · CIK 0001158599 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,143 F1 · price: The price reported in this row represents a weighted average price of $56.87 per share. These shares were purchased in multiple transactions at prices ranging from $56.83 to $57.01, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price. Read SEC document |
| February 28, 2024 Filed Feb 28, 2024 22:38 UTC |
Laughlin Whitney MChief Legal Officer
|
PurchaseCommon Stock | 863 | $57.74 | $49,829.62 |
DisclosureSEC source: 0001142750-24-000020 · wk-form4_1709159893.xml · nonDerivative · entry 1 Laughlin Whitney M · CIK 0001992434 · Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 14,490 Read SEC document |
| February 27, 2024 Filed Feb 28, 2024 02:02 UTC |
Grace CarolineDirector · Chief Executive Officer
|
PurchaseCommon Stock | 7,583 | $57.06 | $432,685.98 |
DisclosureSEC source: 0001142750-24-000019 · wk-form4_1709085741.xml · nonDerivative · entry 2 Grace Caroline · CIK 0001705516 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 27,178 F2 · price: The price reported in this row represents a weighted average price of $57.06 per share. These shares were purchased in multiple transactions at prices ranging from $56.82 to $57.49, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price. Read SEC document |
| February 27, 2024 Filed Feb 28, 2024 02:02 UTC |
Grace CarolineDirector · Chief Executive Officer
|
PurchaseCommon Stock | 9,917 | $56.39 | $559,219.63 |
DisclosureSEC source: 0001142750-24-000019 · wk-form4_1709085741.xml · nonDerivative · entry 1 Grace Caroline · CIK 0001705516 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 19,595 F1 · price: The price reported in this row represents a weighted average price of $56.39 per share. These shares were purchased in multiple transactions at prices ranging from $55.82 to $56.81, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price. Read SEC document |
| February 22, 2024 Filed Feb 26, 2024 17:18 UTC |
Laughlin Whitney MChief Legal Officer
|
Tax withholdingCommon Stock | 146 | $59.16 | $8,637.36 |
DisclosureSEC source: 0001142750-24-000018 · wk-form4_1708967898.xml · nonDerivative · entry 2 Laughlin Whitney M · CIK 0001992434 · Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13,627 F2 · kind: Number of shares withheld for tax purposes. Read SEC document |
| February 22, 2024 Filed Feb 26, 2024 17:18 UTC |
Laughlin Whitney MChief Legal Officer
|
GrantCommon Stock | 490 | $0.00 | $0.00 |
DisclosureSEC source: 0001142750-24-000018 · wk-form4_1708967898.xml · nonDerivative · entry 1 Laughlin Whitney M · CIK 0001992434 · Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13,773 F1 · kind: The acquisition of Common Stock set forth in this row resulted from the vesting of a Performance Restricted Stock Unit ("PRSU") award granted by the Company on January 4, 2021. The ultimate number of PRSUs that could have been earned and vested under this award depended on the Company achieving or exceeding, annual year-over-year performance targets based, on a consolidated basis, a certain specified adjusted earnings before interest, taxes, depreciation and amortization ("Adjusted EBITDA") over a three-year period beginning on January 1, 2021 and ended December 31, 2023. As a result, 134% of the target amount of PRSUs for this award were deemed earned and vested. Read SEC document |
| February 22, 2024 Filed Feb 26, 2024 17:15 UTC |
Hagan Mark ChristopherChief Information and Digital
|
Tax withholdingCommon Stock | 1,879 | $59.16 | $111,161.64 |
DisclosureSEC source: 0001142750-24-000017 · wk-form4_1708967686.xml · nonDerivative · entry 2 Hagan Mark Christopher · CIK 0001806483 · Chief Information and Digital 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 28,049 F2 · kind: Number of shares withheld for tax purposes. Read SEC document |
| February 22, 2024 Filed Feb 26, 2024 17:15 UTC |
Hagan Mark ChristopherChief Information and Digital
|
GrantCommon Stock | 5,154 | $0.00 | $0.00 |
DisclosureSEC source: 0001142750-24-000017 · wk-form4_1708967686.xml · nonDerivative · entry 1 Hagan Mark Christopher · CIK 0001806483 · Chief Information and Digital 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 29,928 F1 · kind: The acquisition of Common Stock set forth in this row resulted from the vesting of a Performance Restricted Stock Unit ("PRSU") award granted by the Company on January 4, 2021. The ultimate number of PRSUs that could have been earned and vested under this award depended on the Company achieving or exceeding, annual year-over-year performance targets based, on a consolidated basis, a certain specified adjusted earnings before interest, taxes, depreciation and amortization ("Adjusted EBITDA") over a three-year period beginning on January 1, 2021 and ended December 31, 2023. As a result, 134% of the target amount of PRSUs for this award were deemed earned and vested. Read SEC document |
| January 15, 2024 Filed Jan 18, 2024 00:11 UTC | GrantRestricted Stock Units · Derivative | 9,083 | $0.00 | $0.00 |
DisclosureSEC source: 0001142750-24-000010 · wk-form4_1705536676.xml · derivative · entry 7 Knudson Jeffrey R · CIK 0001752946 · CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,083 Underlying: Common Stock · 9,083 shares Expires not disclosed F3 · derivative.exercise_price: The Restricted Stock Units identified in this row were granted pursuant to the AMN Healthcare 2017 Equity Plan. Each Restricted Stock Unit represents a contingent right to receive one share of AMN Common Stock. F7 · derivative.exercise_date: The Restricted Stock Units identified in this row were granted on January 15, 2024 and vest in three tranches on each of the first, second and third anniversaries of the grant date and the grantee's provision of three periods of credited service. F5 · derivative.expiration_date: Restricted Stock Units do not have an expiration date. Read SEC document |
|
| January 15, 2024 Filed Jan 18, 2024 00:11 UTC | Exercise / conversionRestricted Stock Units · Derivative | 1,599 | $0.00 | $0.00 |
DisclosureSEC source: 0001142750-24-000010 · wk-form4_1705536676.xml · derivative · entry 6 Knudson Jeffrey R · CIK 0001752946 · CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,648 Underlying: Common Stock · 1,599 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: The Restricted Stock Units identified in this row were granted pursuant to the AMN Healthcare 2017 Equity Plan. Each Restricted Stock Unit represents a contingent right to receive one share of AMN Common Stock. F6 · derivative.exercise_date: The Restricted Stock Units identified in this row were granted on January 15, 2022 and vest in three tranches on the first, second and third anniversaries of the grant date and the grantee's provision of three periods of credited service. F5 · derivative.expiration_date: Restricted Stock Units do not have an expiration date. Read SEC document |
|
| January 15, 2024 Filed Jan 18, 2024 00:11 UTC | Exercise / conversionRestricted Stock Units · Derivative | 1,890 | $0.00 | $0.00 |
DisclosureSEC source: 0001142750-24-000010 · wk-form4_1705536676.xml · derivative · entry 5 Knudson Jeffrey R · CIK 0001752946 · CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,838 Underlying: Common Stock · 1,890 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: The Restricted Stock Units identified in this row were granted pursuant to the AMN Healthcare 2017 Equity Plan. Each Restricted Stock Unit represents a contingent right to receive one share of AMN Common Stock. F4 · derivative.exercise_date: The Restricted Stock Units identified in this row were granted on January 15, 2023 and vest in three tranches on the first, second and third anniversaries of the grant date and the grantee's provision of three periods of credited service. F5 · derivative.expiration_date: Restricted Stock Units do not have an expiration date. Read SEC document |
|
| January 15, 2024 Filed Jan 18, 2024 00:11 UTC | Tax withholdingCommon Stock | 491 | $77.06 | $37,836.46 |
DisclosureSEC source: 0001142750-24-000010 · wk-form4_1705536676.xml · nonDerivative · entry 4 Knudson Jeffrey R · CIK 0001752946 · CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 20,853 F2 · kind: Number of shares withheld for tax purposes. Read SEC document |
|
| January 15, 2024 Filed Jan 18, 2024 00:11 UTC | Exercise / conversionCommon Stock | 1,890 | $0.00 | $0.00 |
DisclosureSEC source: 0001142750-24-000010 · wk-form4_1705536676.xml · nonDerivative · entry 3 Knudson Jeffrey R · CIK 0001752946 · CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 21,344 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Common Stock acquired on the vesting of Restricted Stock Units. Read SEC document |
|
| January 15, 2024 Filed Jan 18, 2024 00:11 UTC | Tax withholdingCommon Stock | 475 | $77.06 | $36,603.50 |
DisclosureSEC source: 0001142750-24-000010 · wk-form4_1705536676.xml · nonDerivative · entry 2 Knudson Jeffrey R · CIK 0001752946 · CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 19,454 F2 · kind: Number of shares withheld for tax purposes. Read SEC document |
|
| January 15, 2024 Filed Jan 18, 2024 00:11 UTC | Exercise / conversionCommon Stock | 1,599 | $0.00 | $0.00 |
DisclosureSEC source: 0001142750-24-000010 · wk-form4_1705536676.xml · nonDerivative · entry 1 Knudson Jeffrey R · CIK 0001752946 · CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 19,929 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Common Stock acquired on the vesting of Restricted Stock Units. Read SEC document |
|
| January 15, 2024 Filed Jan 18, 2024 00:04 UTC |
Hagan Mark ChristopherChief Information and Digital
|
GrantRestricted Stock Units · Derivative | 6,812 | $0.00 | $0.00 |
DisclosureSEC source: 0001142750-24-000009 · wk-form4_1705536269.xml · derivative · entry 7 Hagan Mark Christopher · CIK 0001806483 · Chief Information and Digital 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,812 Underlying: Common Stock · 6,812 shares Expires not disclosed F3 · derivative.exercise_price: The Restricted Stock Units identified in this row were granted pursuant to the AMN Healthcare 2017 Equity Plan. Each Restricted Stock Unit represents a contingent right to receive one share of AMN Common Stock. F7 · derivative.exercise_date: The Restricted Stock Units identified in this row were granted on January 15, 2024 and vest in three tranches on each of the first, second and third anniversaries of the grant date and the grantee's provision of three periods of credited service. F5 · derivative.expiration_date: Restricted Stock Units do not have an expiration date. Read SEC document |
| January 15, 2024 Filed Jan 18, 2024 00:04 UTC |
Hagan Mark ChristopherChief Information and Digital
|
Exercise / conversionRestricted Stock Units · Derivative | 1,389 | $0.00 | $0.00 |
DisclosureSEC source: 0001142750-24-000009 · wk-form4_1705536269.xml · derivative · entry 6 Hagan Mark Christopher · CIK 0001806483 · Chief Information and Digital 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,823 Underlying: Common Stock · 1,389 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: The Restricted Stock Units identified in this row were granted pursuant to the AMN Healthcare 2017 Equity Plan. Each Restricted Stock Unit represents a contingent right to receive one share of AMN Common Stock. F6 · derivative.exercise_date: The Restricted Stock Units identified in this row were granted on January 15, 2023 and vest in three tranches on each of the first, second and third anniversaries of the grant date and the grantee's provision of three periods of credited service. F5 · derivative.expiration_date: Restricted Stock Units do not have an expiration date. Read SEC document |
| January 15, 2024 Filed Jan 18, 2024 00:04 UTC |
Hagan Mark ChristopherChief Information and Digital
|
Exercise / conversionRestricted Stock Units · Derivative | 1,333 | $0.00 | $0.00 |
DisclosureSEC source: 0001142750-24-000009 · wk-form4_1705536269.xml · derivative · entry 5 Hagan Mark Christopher · CIK 0001806483 · Chief Information and Digital 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,705 Underlying: Common Stock · 1,333 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: The Restricted Stock Units identified in this row were granted pursuant to the AMN Healthcare 2017 Equity Plan. Each Restricted Stock Unit represents a contingent right to receive one share of AMN Common Stock. F4 · derivative.exercise_date: The Restricted Stock Units set forth in this row were granted on January 15, 2022 and vest in three tranches on each of the first, second, and third anniversaries of the grant date and the grantee's provision of three periods of credited service. F5 · derivative.expiration_date: Restricted Stock Units do not have an expiration date. Read SEC document |
| January 15, 2024 Filed Jan 18, 2024 00:04 UTC |
Hagan Mark ChristopherChief Information and Digital
|
Tax withholdingCommon Stock | 496 | $77.06 | $38,221.76 |
DisclosureSEC source: 0001142750-24-000009 · wk-form4_1705536269.xml · nonDerivative · entry 4 Hagan Mark Christopher · CIK 0001806483 · Chief Information and Digital 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 24,774 F2 · kind: Number of shares withheld for tax purposes. Read SEC document |
| January 15, 2024 Filed Jan 18, 2024 00:04 UTC |
Hagan Mark ChristopherChief Information and Digital
|
Exercise / conversionCommon Stock | 1,389 | $0.00 | $0.00 |
DisclosureSEC source: 0001142750-24-000009 · wk-form4_1705536269.xml · nonDerivative · entry 3 Hagan Mark Christopher · CIK 0001806483 · Chief Information and Digital 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 25,270 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Common Stock acquired on the vesting of Restricted Stock Units. Read SEC document |
| January 15, 2024 Filed Jan 18, 2024 00:04 UTC |
Hagan Mark ChristopherChief Information and Digital
|
Tax withholdingCommon Stock | 476 | $77.06 | $36,680.56 |
DisclosureSEC source: 0001142750-24-000009 · wk-form4_1705536269.xml · nonDerivative · entry 2 Hagan Mark Christopher · CIK 0001806483 · Chief Information and Digital 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 23,881 F2 · kind: Number of shares withheld for tax purposes. Read SEC document |
| January 15, 2024 Filed Jan 18, 2024 00:04 UTC |
Hagan Mark ChristopherChief Information and Digital
|
Exercise / conversionCommon Stock | 1,333 | $0.00 | $0.00 |
DisclosureSEC source: 0001142750-24-000009 · wk-form4_1705536269.xml · nonDerivative · entry 1 Hagan Mark Christopher · CIK 0001806483 · Chief Information and Digital 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 24,357 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Common Stock acquired on the vesting of Restricted Stock Units. Read SEC document |
| January 15, 2024 Filed Jan 17, 2024 22:51 UTC |
Laughlin Whitney MChief Legal Officer
|
GrantRestricted Stock Units · Derivative | 2,270 | $0.00 | $0.00 |
DisclosureSEC source: 0001142750-24-000008 · wk-form4_1705531860.xml · derivative · entry 7 Laughlin Whitney M · CIK 0001992434 · Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,270 Underlying: Common Stock · 2,270 shares Expires not disclosed F3 · derivative.exercise_price: The Restricted Stock Units identified in this row were granted pursuant to the AMN Healthcare 2017 Equity Plan. Each Restricted Stock Unit represents a contingent right to receive one share of AMN Common Stock. F7 · derivative.exercise_date: The Restricted Stock Units identified in this row were granted on January 15, 2024 and vest in three tranches on each of the first, second and third anniversaries of the grant date and the grantee's provision of three periods of credited service. F5 · derivative.expiration_date: Restricted Stock Units do not have an expiration date. Read SEC document |
| January 15, 2024 Filed Jan 17, 2024 22:51 UTC |
Laughlin Whitney MChief Legal Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 195 | $0.00 | $0.00 |
DisclosureSEC source: 0001142750-24-000008 · wk-form4_1705531860.xml · derivative · entry 6 Laughlin Whitney M · CIK 0001992434 · Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 398 Underlying: Common Stock · 195 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: The Restricted Stock Units identified in this row were granted pursuant to the AMN Healthcare 2017 Equity Plan. Each Restricted Stock Unit represents a contingent right to receive one share of AMN Common Stock. F6 · derivative.exercise_date: The Restricted Stock Units identified in this row were granted on January 15, 2023 and vest in three tranches on each of the first, second and third anniversaries of the grant date and the grantee's provision of three periods of credited service. F5 · derivative.expiration_date: Restricted Stock Units do not have an expiration date. Read SEC document |
| January 15, 2024 Filed Jan 17, 2024 22:51 UTC |
Laughlin Whitney MChief Legal Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 133 | $0.00 | $0.00 |
DisclosureSEC source: 0001142750-24-000008 · wk-form4_1705531860.xml · derivative · entry 5 Laughlin Whitney M · CIK 0001992434 · Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 138 Underlying: Common Stock · 133 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: The Restricted Stock Units identified in this row were granted pursuant to the AMN Healthcare 2017 Equity Plan. Each Restricted Stock Unit represents a contingent right to receive one share of AMN Common Stock. F4 · derivative.exercise_date: The Restricted Stock Units identified in this row were granted on January 15, 2022 and vest in three tranches on each of the first, second and third anniversaries of the grant date and the grantee's provision of three periods of credited service. F5 · derivative.expiration_date: Restricted Stock Units do not have an expiration date. Read SEC document |
| January 15, 2024 Filed Jan 17, 2024 22:51 UTC |
Laughlin Whitney MChief Legal Officer
|
Tax withholdingCommon Stock | 58 | $77.06 | $4,469.48 |
DisclosureSEC source: 0001142750-24-000008 · wk-form4_1705531860.xml · nonDerivative · entry 4 Laughlin Whitney M · CIK 0001992434 · Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13,283 F2 · kind: Number of shares withheld for tax purposes. Read SEC document |
| January 15, 2024 Filed Jan 17, 2024 22:51 UTC |
Laughlin Whitney MChief Legal Officer
|
Exercise / conversionCommon Stock | 195 | $0.00 | $0.00 |
DisclosureSEC source: 0001142750-24-000008 · wk-form4_1705531860.xml · nonDerivative · entry 3 Laughlin Whitney M · CIK 0001992434 · Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13,341 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Common Stock acquired on the vesting of Restricted Stock Units. Read SEC document |
| January 15, 2024 Filed Jan 17, 2024 22:51 UTC |
Laughlin Whitney MChief Legal Officer
|
Tax withholdingCommon Stock | 40 | $77.06 | $3,082.40 |
DisclosureSEC source: 0001142750-24-000008 · wk-form4_1705531860.xml · nonDerivative · entry 2 Laughlin Whitney M · CIK 0001992434 · Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13,146 F2 · kind: Number of shares withheld for tax purposes. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.